Atherogenic Dyslipidemia and Atherogenic Index of Plasma in Sudanese Adults with Type 2 Diabetes Mellitus: A Case Control Study
Abstract Background The atherogenic index of plasma (AIP) is an inexpensive composite marker of atherogenic lipid risk that has emerged as a valuable tool in patients with type 2 diabetes mellitus (T2DM), a population which cardiovascular risk is driven substantially by atherogenic dyslipidemia. However case–control data quantifying AIP performance in Sudanese adults with T2DM are lacking. Objective To quantify the burden of atherogenic dyslipidemia and evaluate the diagnostic and independent predictive performance of AIP in Sudanese adults with T2DM relative to healthy controls. Methods In this case control study, 245 adults with T2DM and 245 age- and sex-matched healthy controls were recruited from three teaching hospitals in Al Jazirah State, Sudan. Anthropometric indices and a fasting lipid and glycemic profile were measured, and AIP was calculated as log₁₀(triglycerides/HDL-cholesterol). Group differences were assessed with the Mann-Whitney U and Chi-square tests, associations with Spearman correlation, diagnostic performance with ROC curve analysis, and independent predictors with binary logistic regression adjusting for BMI, waist–hip ratio, and age. Results Cases showed a fully atherogenic lipid profile relative to controls, including significantly higher AIP (median 0.778 vs. 0.497, p < 0.001). Among cases, AIP correlated strongly with VLDL-C (r = 0.638, p < 0.001) but not with FBG, HbA1c, insulin, or HOMA-IR. AIP discriminated cases from controls with good accuracy (AUC = 0.821, 95% CI: 0.784–0.857; optimal cutoff 0.654, sensitivity 75.1%, specificity 73.5%) and remained an independent predictor of T2DM status after adjustment for BMI, waist–hip ratio, and age (Wald = 64.53, p < 0.001; overall model accuracy 87.6%). Conclusion Sudanese adults with T2DM carry a substantially greater atherogenic lipid burden than healthy controls, and AIP is an independent, low-cost marker of this risk that is distinct from glycemic status. AIP may serve as a practical adjunct for cardiovascular risk stratification in resource-limited settings.
Authors
- Abdelgadir Elmugadam (ORCID: https://orcid.org/0000-0002-2285-757X)
- Abuagla M. Dafalla
- Almoeiz Y Hammad
- Ahmed A. Siragalnoor
Institutions
- Kampala International University (UG)
- University of Gezira (SD)
- Sudan University of Science and Technology (SD)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-12
- DOI
- https://doi.org/10.21203/rs.3.rs-11000311/v1
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- preprint